Lilly takes solanezumab for another spin
Deborah Weinstein
December 13 2012
The drug maker will roll out another Phase III trial.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.